Creabilis therapeutics SpA appoints Domenico Criscuolo as Chief Medical Officer
Creabilis therapeutics SpA announced the appointment of Domenico Criscuolo as Chief Medical Officer, effective February 21st, 2007.
Dr Criscuolo graduated in Medicine at the University of Rome and got a PhD in Haematology and another one in Clinical Oncology. He started working as Clinical Research physician in 1975 at Lepetit. In 1985 he moved to Roche Italy as Head of International Clinical Research and Drug Safety, and activated Phase I-III studies in several therapeutic areas including oncology, inflammation, CNS, gastroenterology, antimicrobials and antivirals. In 2001 he moved to Novuspharma - a biotec spin off company of Roche - as Global Head of Clinical Development, and activated Phase I -III studies on four NCEs in the oncology area. From 2003 to 2006 he joined the CRO industry, as VP Regional Operations at ICON, where he established the Italian operations in Milano. He has been President of SSFA, the Italian association of pharma researchers, and President of IFAPP, the International Federation of Pharmaceutical Medicine. He is teacher at Bocconi Business School on Project management and leadership.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
